Public Release: 

Olivier Bruyère named winner of IOF Olof Johnell Science Award

Prestigious annual Award recognizes distinguished researcher for achievements in musculoskeletal research and policy implementation

International Osteoporosis Foundation

The 2017 International Osteoporosis Foundation (IOF) Olof Johnell Science Award was presented to Professor Olivier Bruyère at a ceremony held today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Florence, Italy. The Award recognizes extraordinary and internationally recognized contributions to the field of osteoporosis in a scientific or policy implementation area. It is named in honour of the late Professor Olof Johnell, a Swedish orthopaedic surgeon who made major contributions to the field of osteoporosis and to the work of IOF.

The Award was presented to Professor Bruyère by the Chair of the IOF Committee of Scientific Advisors, Professor Cyrus Cooper, who stated: "I am pleased to extend this prestigious award to Professor Olivier Bruyère on behalf of IOF. Presented in recognition of his extensive body of work across a broad spectrum of musculoskeletal research, this Award also pays special tribute to Professor Bruyère's achievements in the fields of epidemiology and public health and to his commitment to education and teaching. He has pioneered an important initiative of the Foundation through his novel course on research methods."

Olivier Bruyère is Professor of Clinical Epidemiology in the Department of Public Health, Epidemiology and Health Economics, Professor of Geriatrics Rehabilitation in the Department of Motricity Sciences, and Head, Support Unit, Epidemiology and Biostatistics, at the University of Liège, Belgium. His areas of interest include epidemiology, public health, health economics, pharmacoepidemiology, physiotherapy, sport and rehabilitation, quality of life, geriatrics, nutrition, economic evaluation of the prevention and treatment of osteoarthritis, osteoporosis and frailty.

Prof. Bruyère has published more than 200 scientific papers and is, among other positions, the Editor-in-Chief of 'Archives of Public Health', Associate Editor of 'BMC Musculoskeletal Disorders', Expert at the European Food Safety Authority (EFSA) and at the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Member of the Scientific Advisory Board of the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), General Secretary of the Belgian Bone Club (BBC), Member of IOF Committee of Scientific Advisors, and President of the Belgian Ageing Muscle Society. He has received several internationally recognized awards, including the 2016 IOF-ESCEO Pierre Meunier Young Science Award.

###

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017):

Held jointly by IOF and ESCEO, the Congress takes place in Florence, Italy, from March 23-26, 2017. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. Congress abstracts will be published in Osteoporosis International, Volume 28, Supplement 1, March 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF:

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 237 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.iofbonehealth.org http://www.facebook.com/ @iofbonehealth

About ESCEO:

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.